Ovid Therapeutics (OVID) Earnings Date & Reports

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

OVID is expected to report earnings to fall 5.83% to -11 cents per share on August 18

Ovid Therapeutics OVID Stock Earnings Reports

Q2'26

Est.

$-0.11

Q1'26

Est.

$-0.12

Q4'25

Beat

by $0.17

Q3'25

Missed

by $0.02

Q2'25

Beat

by $0.10

The last earnings report on May 12 showed earnings per share of -11 cents, meeting the estimate of -11 cents. With 222.75K shares outstanding, the current market capitalization sits at 419.94M.

View a ticker or compare two or three

Compare

OVID

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for OVID